Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Nov;90(5):2123-9.
doi: 10.1172/JCI116097.

Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood

Affiliations

Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood

L E DeForge et al. J Clin Invest. 1992 Nov.

Abstract

The hydroxyl radical (OH.) scavenger dimethyl sulfoxide (DMSO) was found to dose-dependently inhibit interleukin 8 (IL-8) production in LPS-stimulated human whole blood. At a concentration of 1% (vol/vol), DMSO blocked IL-8 release by approximately 90% in the presence of 1 microgram/ml LPS at a 24-h time point, but did not affect cell viability or reduce the production of tumor necrosis factor (TNF), interleukin 6, or interleukin-1 beta (IL-1 beta). DMSO was found to directly inhibit IL-8 expression at the level of transcription. Furthermore, this effect was not LPS-specific, in that IL-8 production was reduced by DMSO to a similar extent upon stimulation of blood with phytohemagglutinin, aggregated immune complexes, TNF, or IL-1 beta. Other oxygen radical scavengers that have been shown to inhibit OH.-dependent reactions (dimethyl thiourea, thiourea, mannitol, and ethanol) also inhibited IL-8 production. Conversely, addition of H2O2 caused a dose-dependent stimulation of IL-8 release. These results provide evidence that reactive oxygen metabolites play an important role in the regulation of IL-8 production and suggest that reduction of IL-8 release may contribute to the beneficial effects of antioxidants in experimental models of inflammation and ischemia/reperfusion injury.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Invest. 1990 Feb;19(1):69-79 - PubMed
    1. Eur J Immunol. 1987 Oct;17(10):1411-6 - PubMed
    1. Clin Exp Rheumatol. 1990 Jul-Aug;8(4):387-91 - PubMed
    1. J Clin Invest. 1990 Nov;86(5):1556-64 - PubMed
    1. Am J Physiol. 1990 Dec;259(6 Pt 1):G907-12 - PubMed

Publication types